$2.29

0.37 (19.27%)

7/18/2008 3:55 PM

Neptune Technologies (NEPT)

CAPS Rating:

The Company develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

NEPT doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Players

7 Outperforms

96 Underperforms

All-Stars

2 Outperforms

69 Underperforms

Players bullish on NEPT are also bullish on:

Players bearish on NEPT are also bearish on:

Ticker Tags

Biotechnology (293), Micro Cap (4824)
Suggest a tag

Neptune Technologies At A Glance

Current Price:	$2.29
Last Trade Time:	7/18/2008 3:55 PM
Open:	$2.23
Previous Close:	$1.92
Daily Range:	$2.10 - $2.29
52-Week Range:	$1.61 - $6.09
Volume:	700
Market Cap:	$71.85M
P/E Ratio:	0.00
Compare Our Special Broker Offers!

Stock Trends

NEPT VS S&P 500 (SPY)

News & Discussion Boards

Sorry no news articles available for NEPT.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

Recs

3 Neptune Technologies (NEPT)

Avatar themattgrdt (99.79) Submitted: 1/23/08 3:51 PM

I hate rating stocks with low volume. It seems to wreak havok on the CAPS system. I waited about an hour after this thing spiked 20% to thumbs down it, and I get a 2.76 start price? What the hell :(

Replies: 3 | Reply | Permalink

CAPS Players

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 13 : 1 2 3 Next »

Show Pitch Replies

Recs 0 (NEPT) manvsmonkey (92.29) Submitted: 6/14/08 12:38 PM : Start Price: $2.50 NEPT Score: 0.88 The wolf pack has arrived Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (NEPT) Gtrinvestor (99.97) Submitted: 6/13/08 3:00 PM : Start Price: $2.99 NEPT Score: 16.31 Re-load, but here is my original rant: I can't tell you which part of this press release screams "pump / scam" to me more... that fact that they did a "reorg" when they only have 9 employees or the fact that stock-based comp expense was half of sales for the past quarter. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (NEPT) MrBuffetSentme (27.67) Submitted: 5/02/08 10:59 PM : Start Price: $3.70 NEPT Score: -27.47 meds a big buss Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (NEPT) tripleornothing (< 20) Submitted: 2/22/08 10:59 AM : Start Price: $3.35 NEPT Score: -26.22 I expect the stock to be overall stagnant (yet fluctuating) for awhile, but to eventually have some nice growth once benefits are more widely known. Already studies support use for hyperlipidemia (lowers bad LDL cholesterol while raising good HDL cholesterol), ADHD, PMS, arthritis/aches/pains/inflammation (significantly reduces CRP markers), and skin health. This is despite some of the studies using tiny doses which are only 1/4th the amount that is in the product serving (which is two very small gelcaps or capliques). Here are some supporting studies that I have bookmarked (there are more besides these actually) : http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowD... , http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowD... , and http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowD... Doctor Mike give a good overall summary of it's pain relieving effects at http://www.proteinpower.com/drmike/uncategorized/why-krill-o... It has been shown to be significantly more effective than fish oil for controlling hyperlipidemia. The advantages over fish oil (or less advanced krill oils) being it's much better absorbing phospholipid form (rich in choline) and inherent high antioxidant capacity (over 300x greater than vitamin E for instance). Yeah, right now people hear about krill oil and think "WTF? Must be some marketing garbage." Thus far there hasn't been much of a public promotion (besides press releases that only investors would read). Slowly though word is getting out and major health gurus such as Dr. Mercola, Dr. Weill (such as his featured article in Time Magazine), and Dr. Mike Eades have all recently endorsed krill oil and will likely snowball further exposure. The deal with Yoplait (yogurt) will be able to move foward now that NKO has been given GRAS status in the U.S.A (allowing it to be used in functional food). That would be a huge boon to recognition of NKO. In summary I'd say this stock definitely has some long term potential (2 to 4 years), meaning the skeptics may want to wait and see if these recent developments (increased exposure) help out the companies thus far lagging finances. Personally I know the stuff works (helped with my mood and knee pains), so I'm no skeptic. Report this Post Replies: 1 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 3 (NEPT) themattgrdt (99.79) Submitted: 1/23/08 3:51 PM : Start Price: $2.76 NEPT Score: 14.36 I hate rating stocks with low volume. It seems to wreak havok on the CAPS system. I waited about an hour after this thing spiked 20% to thumbs down it, and I get a 2.76 start price? What the hell :( Report this Post Replies: 3 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 13 : 1 2 3 Next »

Wall Street

There are no Wall Street player picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.